Annual D&A
$3.56 M
+$588.00 K+19.75%
31 December 2023
Summary:
Kymera Therapeutics annual depreciation & amortization is currently $3.56 million, with the most recent change of +$588.00 thousand (+19.75%) on 31 December 2023. During the last 3 years, it has risen by +$1.17 million (+48.73%). KYMR annual D&A is now at all-time high.KYMR Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$1.99 M
+$49.00 K+2.53%
30 September 2024
Summary:
Kymera Therapeutics quarterly depreciation & amortization is currently $1.99 million, with the most recent change of +$49.00 thousand (+2.53%) on 30 September 2024. Over the past year, it has increased by +$1.10 million (+123.01%). KYMR quarterly D&A is now at all-time high.KYMR Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$6.28 M
+$1.09 M+21.06%
30 September 2024
Summary:
Kymera Therapeutics TTM depreciation & amortization is currently $6.28 million, with the most recent change of +$1.09 million (+21.06%) on 30 September 2024. Over the past year, it has increased by +$2.71 million (+76.07%). KYMR TTM D&A is now at all-time high.KYMR TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KYMR Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +123.0% | +76.1% |
| 3 y3 years | +48.7% | +188.4% | +161.9% |
| 5 y5 years | +332.1% | - | - |
KYMR Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +48.7% | at high | +189.2% | at high | +161.9% |
| 5 y | 5 years | at high | +332.1% | at high | +413.4% | at high | +1522.0% |
| alltime | all time | at high | +1639.0% | at high | +413.4% | at high | +1522.0% |
Kymera Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.99 M(+2.5%) | $6.28 M(+21.1%) |
| June 2024 | - | $1.94 M(+32.6%) | $5.18 M(+25.0%) |
| Mar 2024 | - | $1.46 M(+64.0%) | $4.15 M(+16.3%) |
| Dec 2023 | $3.56 M(+19.8%) | $891.00 K(-0.4%) | $3.56 M(+2.1%) |
| Sept 2023 | - | $895.00 K(-0.6%) | $3.49 M(+3.8%) |
| June 2023 | - | $900.00 K(+2.4%) | $3.36 M(+6.2%) |
| Mar 2023 | - | $879.00 K(+7.5%) | $3.17 M(+6.4%) |
| Dec 2022 | $2.98 M | $818.00 K(+6.6%) | $2.98 M(+4.5%) |
| Sept 2022 | - | $767.00 K(+8.8%) | $2.85 M(+3.5%) |
| June 2022 | - | $705.00 K(+2.6%) | $2.75 M(+5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $687.00 K(-0.3%) | $2.60 M(+8.4%) |
| Dec 2021 | $2.40 M(+36.0%) | $689.00 K(+2.7%) | $2.40 M(+8.7%) |
| Sept 2021 | - | $671.00 K(+21.6%) | $2.21 M(+8.9%) |
| June 2021 | - | $552.00 K(+13.8%) | $2.02 M(+8.8%) |
| Mar 2021 | - | $485.00 K(-2.4%) | $1.86 M(+5.6%) |
| Dec 2020 | $1.76 M(+113.7%) | $497.00 K(+1.4%) | $1.76 M(+39.3%) |
| Sept 2020 | - | $490.00 K(+26.0%) | $1.27 M(+63.1%) |
| June 2020 | - | $389.00 K(+0.5%) | $776.00 K(+100.5%) |
| Mar 2020 | - | $387.00 K | $387.00 K |
| Dec 2019 | $825.00 K(+302.4%) | - | - |
| Dec 2018 | $205.00 K | - | - |
FAQ
- What is Kymera Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly D&A year-on-year change?
- What is Kymera Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Kymera Therapeutics?
- What is Kymera Therapeutics TTM D&A year-on-year change?
What is Kymera Therapeutics annual depreciation & amortization?
The current annual D&A of KYMR is $3.56 M
What is the all time high annual D&A for Kymera Therapeutics?
Kymera Therapeutics all-time high annual depreciation & amortization is $3.56 M
What is Kymera Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of KYMR is $1.99 M
What is the all time high quarterly D&A for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly depreciation & amortization is $1.99 M
What is Kymera Therapeutics quarterly D&A year-on-year change?
Over the past year, KYMR quarterly depreciation & amortization has changed by +$1.10 M (+123.01%)
What is Kymera Therapeutics TTM depreciation & amortization?
The current TTM D&A of KYMR is $6.28 M
What is the all time high TTM D&A for Kymera Therapeutics?
Kymera Therapeutics all-time high TTM depreciation & amortization is $6.28 M
What is Kymera Therapeutics TTM D&A year-on-year change?
Over the past year, KYMR TTM depreciation & amortization has changed by +$2.71 M (+76.07%)